tetano
Editor, Senior Moderator
Clin Infect Dis
. 2021 Dec 24;ciab1048.
doi: 10.1093/cid/ciab1048. Online ahead of print.
COVID-19 breakthrough infection and post-vaccination neutralizing antibody among healthcare workers in a referral hospital in Tokyo: a case-control matching study
Shohei Yamamoto[SUP] 1 [/SUP], Kenji Maeda[SUP] 2 [/SUP], Kouki Matsuda[SUP] 2 [/SUP], Akihito Tanaka[SUP] 3 [/SUP], Kumi Horii[SUP] 4 [/SUP], Kaori Okudera[SUP] 5 [/SUP], Junko S Takeuchi[SUP] 6 [/SUP], Tetsuya Mizoue[SUP] 1 [/SUP], Maki Konishi[SUP] 1 [/SUP], Mitsuru Ozeki[SUP] 3 [/SUP], Haruhito Sugiyama[SUP] 7 [/SUP], Nobuyoshi Aoyanagi[SUP] 8 [/SUP], Hiroaki Mitsuya[SUP] 2 [/SUP], Wataru Sugiura[SUP] 9 [/SUP], Norio Ohmagari[SUP] 10 [/SUP]
Affiliations
Abstract
Background: While increasing coverage of effective vaccines against coronavirus disease 2019 (COVID-19), emergent variants raise concerns about breakthrough infection. Data are limited, however, whether breakthrough infection during the epidemic of the variant is ascribed to insufficient vaccine-induced immunogenicity.
Methods: We described incident COVID-19 in relation to the vaccination program among workers of a referral hospital in Tokyo. During the predominantly Delta epidemic, we followed 2,415 fully vaccinated staff (BNT162b2) for breakthrough infection and selected three matched controls. We measured post-vaccination neutralizing antibodies against the wild-type, Alpha (B.1.1.7), and Delta (B.1.617.2) strains using live viruses and anti-spike antibodies using quantitative assays, and compared them using the generalized estimating equation model between the two groups.
Results: No COVID-19 cases occurred 1-2 months after the vaccination program during the fourth epidemic wave in Japan, dominated by the Alpha variant, while 22 cases emerged 2-4 months after the vaccination program during the fifth wave, dominated by the Delta variant. In the vaccinated cohort, all 17 cases of breakthrough infection were mild or asymptomatic and had returned to work early. There was no measurable difference between cases and controls in post-vaccination neutralizing antibody titers against the wild-type, Alpha, and Delta, and anti-spike antibody titers, while neutralizing titers against the variants were considerably lower than those against the wild-type.
Conclusions: Post-vaccination neutralizing antibody titers were not decreased among patients with breakthrough infection relative to their controls under the Delta variant rampage. The result points to the importance of infection control measures in the post-vaccination era, irrespective of immunogenicity profile.
Keywords: COVID-19; breakthrough infection; neutralizing antibody; vaccination.
. 2021 Dec 24;ciab1048.
doi: 10.1093/cid/ciab1048. Online ahead of print.
COVID-19 breakthrough infection and post-vaccination neutralizing antibody among healthcare workers in a referral hospital in Tokyo: a case-control matching study
Shohei Yamamoto[SUP] 1 [/SUP], Kenji Maeda[SUP] 2 [/SUP], Kouki Matsuda[SUP] 2 [/SUP], Akihito Tanaka[SUP] 3 [/SUP], Kumi Horii[SUP] 4 [/SUP], Kaori Okudera[SUP] 5 [/SUP], Junko S Takeuchi[SUP] 6 [/SUP], Tetsuya Mizoue[SUP] 1 [/SUP], Maki Konishi[SUP] 1 [/SUP], Mitsuru Ozeki[SUP] 3 [/SUP], Haruhito Sugiyama[SUP] 7 [/SUP], Nobuyoshi Aoyanagi[SUP] 8 [/SUP], Hiroaki Mitsuya[SUP] 2 [/SUP], Wataru Sugiura[SUP] 9 [/SUP], Norio Ohmagari[SUP] 10 [/SUP]
Affiliations
- PMID: 34950947
- DOI: 10.1093/cid/ciab1048
Abstract
Background: While increasing coverage of effective vaccines against coronavirus disease 2019 (COVID-19), emergent variants raise concerns about breakthrough infection. Data are limited, however, whether breakthrough infection during the epidemic of the variant is ascribed to insufficient vaccine-induced immunogenicity.
Methods: We described incident COVID-19 in relation to the vaccination program among workers of a referral hospital in Tokyo. During the predominantly Delta epidemic, we followed 2,415 fully vaccinated staff (BNT162b2) for breakthrough infection and selected three matched controls. We measured post-vaccination neutralizing antibodies against the wild-type, Alpha (B.1.1.7), and Delta (B.1.617.2) strains using live viruses and anti-spike antibodies using quantitative assays, and compared them using the generalized estimating equation model between the two groups.
Results: No COVID-19 cases occurred 1-2 months after the vaccination program during the fourth epidemic wave in Japan, dominated by the Alpha variant, while 22 cases emerged 2-4 months after the vaccination program during the fifth wave, dominated by the Delta variant. In the vaccinated cohort, all 17 cases of breakthrough infection were mild or asymptomatic and had returned to work early. There was no measurable difference between cases and controls in post-vaccination neutralizing antibody titers against the wild-type, Alpha, and Delta, and anti-spike antibody titers, while neutralizing titers against the variants were considerably lower than those against the wild-type.
Conclusions: Post-vaccination neutralizing antibody titers were not decreased among patients with breakthrough infection relative to their controls under the Delta variant rampage. The result points to the importance of infection control measures in the post-vaccination era, irrespective of immunogenicity profile.
Keywords: COVID-19; breakthrough infection; neutralizing antibody; vaccination.